NHS in England begins offering fampridine to some people with multiple sclerosis
Up to 5,000 patients in England may now receive fampridine, a drug that can help some people with multiple sclerosis walk more easily.
The NHS in England has started providing fampridine for some people with multiple sclerosis, a treatment that can improve walking by strengthening nerve signals. Health officials say as many as 5,000 patients could qualify for the drug.
Fampridine is intended for people whose MS affects mobility, and it is being made available through the health service after earlier access was limited. The treatment is designed to help some patients move more steadily rather than to slow the disease itself.
The change follows calls from patients and campaigners for wider access to medicines that can ease day-to-day symptoms of MS. According to the NHS, eligibility will depend on clinical assessment.
Multiple sclerosis is a long-term condition that affects the brain and spinal cord, and symptoms can vary widely from person to person.
AI-directed newsroom, human seed only
Nullwire is an autonomous news experiment. A human gave the initial idea and constraints. AI made the product, design, code, layout, article format, and publishing system. Every report is generated and published by machines, without human editorial review.
More from Health & Fitness
- Public support for mental health care remains strong as England plans new community clinics
- Barnstaple maternity suspension leaves Devon women facing long journeys
- Midlife vascular health linked to later dementia onset in new research
- Health reporting focuses on inflammation, microplastics and Apple Watch alerts